Detalles de la búsqueda
1.
Replacing cyclophosphamide/cytarabine/mercaptopurine with cyclophosphamide/etoposide during consolidation/delayed intensification does not improve outcome for pediatric B-cell acute lymphoblastic leukemia: a report from the COG.
Haematologica
; 104(5): 986-992, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30545921
2.
Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131.
Cancer
; 124(6): 1150-1159, 2018 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29266189
3.
KMT2A partner genes in infant acute lymphoblastic leukemia have prognostic significance and correlate with age, white blood cell count, sex, and central nervous system involvement: a Children's Oncology Group P9407 trial study.
Haematologica
; 108(10): 2865-2871, 2023 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36861410
4.
Outstanding outcomes in infants with KMT2A-germline acute lymphoblastic leukemia treated with chemotherapy alone: results of the Children's Oncology Group AALL0631 trial.
Haematologica
; 107(5): 1205-1208, 2022 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35172563
5.
Early career mentoring through the American Society of Pediatric Hematology/Oncology: Lessons learned from a pilot program.
Pediatr Blood Cancer
; 64(3)2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27616578
6.
Risk factors for bacteremia and central line-associated blood stream infections in children with acute myelogenous leukemia: A single-institution report.
Pediatr Blood Cancer
; 64(3)2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27616655
7.
Potent obatoclax cytotoxicity and activation of triple death mode killing across infant acute lymphoblastic leukemia.
Blood
; 121(14): 2689-703, 2013 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-23393050
8.
Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: a report from the Children's Oncology Group.
Pediatr Blood Cancer
; 62(3): 414-8, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25407157
9.
Intensified chemotherapy without SCT in infant ALL: results from COG P9407 (Cohort 3).
Pediatr Blood Cancer
; 62(3): 419-26, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25399948
10.
High colonization rate and prolonged shedding of Clostridium difficile in pediatric oncology patients.
Clin Infect Dis
; 59(3): 401-3, 2014 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24785235
11.
Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study.
Blood
; 119(8): 1872-81, 2012 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-22210879
12.
Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971.
Blood
; 118(26): 6752-9; quiz 6996, 2011 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-21849481
13.
Genetic variants modify susceptibility to leukemia in infants: a Children's Oncology Group report.
Pediatr Blood Cancer
; 60(1): 31-4, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22422485
14.
Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced-dose chemotherapy on Children's Oncology Group trial A2971: a report from the Children's Oncology Group.
Cancer
; 118(19): 4806-14, 2012 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22392565
15.
End-of-life experience of children undergoing stem cell transplantation for malignancy: parent and provider perspectives and patterns of care.
Blood
; 115(19): 3879-85, 2010 May 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-20228275
16.
Modifications to induction therapy decrease risk of early death in infants with acute lymphoblastic leukemia treated on Children's Oncology Group P9407.
Pediatr Blood Cancer
; 59(5): 834-9, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22488662
17.
MLL gene rearrangements in infant leukemia vary with age at diagnosis and selected demographic factors: a Children's Oncology Group (COG) study.
Pediatr Blood Cancer
; 58(6): 836-9, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21800415
18.
Maternal exposure to household chemicals and risk of infant leukemia: a report from the Children's Oncology Group.
Cancer Causes Control
; 22(8): 1197-204, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21691732
19.
FLT3 inhibitor lestaurtinib plus chemotherapy for newly diagnosed KMT2A-rearranged infant acute lymphoblastic leukemia: Children's Oncology Group trial AALL0631.
Leukemia
; 35(5): 1279-1290, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33623141
20.
Infant leukemia and congenital abnormalities: a Children's Oncology Group study.
Pediatr Blood Cancer
; 55(1): 95-9, 2010 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20486175